Szukaj
Wyświetlanie pozycji 1-2 z 2
Presence of Akkermansiaceae in gut microbiome and immunotherapy effectiveness in patients with advanced non-small cell lung cancer
(Springer Open Journal, 2022)
The significance of Akkermansia bacteria presence in gut micobiome, mainly Akkermansia mucinifila, is currently being investigated in the context of supporting therapy and marker for response to immunotherapy in cancer ...
Attempting to identify bacterial allies in immunotherapy of NSCLC patients
(MDPI, 2022)
Introduction: Factors other than PD-L1 (Programmed Death Ligand 1) are being sought
as predictors for cancer immuno- or chemoimmunotherapy in ongoing studies and long-term ob-
servations. Despite high PD-L1 expression ...